-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cyclosporin H is a semi-synthetic cyclic peptide that is widely used in the pharmaceutical industry as an immunosuppressant drug.
Its production process requires a combination of chemical synthesis and biotechnology techniques.
In this article, we will discuss the production process of Cyclosporin H in detail.
Step 1: Chemical Synthesis of Cyclosporin H
The first step in the production of Cyclosporin H involves the chemical synthesis of the naturally occurring cyclic peptide, called algal precursor.
This precursor is a steroid produced by certain species of algae, which is used as a starting material for the synthesis of Cyclosporin H.
Step 2: Purification of Algal Precursor
The algal precursor is purified using various chromatography techniques, such as high-performance liquid chromatography (HPLC) and gel filtration chromatography.
This step is important for the removal of impurities and the isolation of the Algal precursor in a pure form.
Step 3: Biotechnological Conversion of Algal Precursor to Cyclosporin H
The purified Algal precursor is then converted to Cyclosporin H using a biotechnological process, typically using a microbial fermentation process.
The fermentation process involves the use of genetically modified bacteria, such as Pichia pastoris or Saccharomyces cerevisiae, which have been engineered to express the enzymes required for the conversion of Algal precursor to Cyclosporin H.
Step 4: Purification and Isolation of Cyclosporin H
After the fermentation process, the resulting crude fermentation broth is purified and concentrated using various techniques such as precipitation, filtration, and chromatography.
The purified Cyclosporin H is then isolated in a solid form and dried.
Step 5: Characterization and Quality Control
The final step in the production process of Cyclosporin H is the characterization and quality control of the product.
The purity and identity of the final product are verified using various techniques such as HPLC, mass spectrometry, and nuclear magnetic resonance spectroscopy (NMR).
The quality of the final product is also evaluated based on its biological activity, which is determined using in-vitro and in-vivo assays.
Variations of the Production Process
The production process of Cyclosporin H can vary depending on the manufacturing process and the scale of production.
Some manufacturers may use different fermentation media or purification methods to produce the drug.
In addition, the production process may also vary depending on the intended use of the product.
For example, the production process for use in humans may differ from the process used for veterinary applications.
Challenges in Production
The production of Cyclosporin H can be challenging due to several reasons.
One of the main challenges is the high cost of production, which can be attributed to the complexity of the production process and the need for specialized equipment and facilities.
In addition, the biotechnological conversion of the Algal precursor to Cyclosporin H can be affected by factors such as oxygen availability, pH, and temperature, which can impact the yield and quality of the final product.
Conclusion
The production process of Cyclosporin H involves the use of chemical synthesis and biotechnology techniques.
The process involves the purification of the Algal precursor, its conversion to Cyclosporin H using a biotechnological process, and its purification and isolation in a pure form.
The final step in the process is the characterization and quality control of the product, which is essential for ensuring its purity and biological activity.
The production process of Cyclosporin H can be challenging due to the high cost of production and the sensitivity of the biotechnological process to several factors.